Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Drug Diversion Act

Executive Summary

Proposed rule for state regulation of drug wholesalers is expected to be available within the next two weeks, FDA said. The guideline proposes minimum standards for storage and handling, record keeping, and licensing. States will use the guidelines as a basis for developing their own regulations. Wholesalers must be licensed by the state two years after FDA publishes the final rule, the agency said. In addition, a guidance letter to industry on implementation of the act is expected to be available the week of Aug. 1 ("The Pink Sheet" July 25, T&G-1).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS014045

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel